This 11-week study will examine the safety and effectiveness of the medication donepezil
(Aricept®) compared to placebo for treating cognitive deficits in children and adolescents
with Autism Spectrum Disorder.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Mental Health (NIMH) University of Pittsburgh